Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
eli lilly
2
×
fda
2
×
indiana blog main
2
×
indiana top stories
lasmiditan
life sciences
national blog main
raleigh-durham blog main
raleigh-durham top stories
teva pharmaceutical
triptans
abalos therapeutics
acetonid
achillion pharmaceuticals
aglios therapeutics
alexion pharmaceuticals
alprazolam
amgen
amy peterson
aresenalbio
armo biosciences
asklepios biopharmaceutical
azitra
boston top stories
boulder/denver blog main
boulder/denver top stories
bridgebio
cancer
cancer immunotherapy
cgrp inhibitors
checkmate pharmaceuticals
chemotherapy
chronic migraine
clinical trials
colucid pharmaceuticals
crispr
crispr therapeutics
cyteir therapeutics
What
new
2
×
pharmaceutical
2
×
acute
addresses
approval
bails
bio
brand
bridgebio
capital
car
causes
condition
decades
develop
drug
drugs
eli
emerges
fda
firm
friday
giant
giving
grab
headlines
ichnos
invest
lasmiditan
life
lilly
lilly’s
medication
migraine
millions
oks
roundup
science
second
tens
Language
unset
Current search:
pharmaceutical
×
fda
×
" indiana blog main "
×
new
×
" eli lilly "
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades